Skip to main content
. 2007 Apr 10;96(10):1520–1525. doi: 10.1038/sj.bjc.6603732

Table 2. EC50 values of Doxorubicin-treated SK-BR-3 cells with and without peptides.

  Doxorubicin Doxorubicin+5.0 × 10−6 M G7-18NATE-P Doxorubicin+1 × 10−5 M G7-18NATE-P Doxorubicin+5.0 × 10−6 M Penetratin Doxorubicin+1 × 10−5 M Penetratin
Best fit 1.2 × 10−6 5.2 × 10−7 1.9 × 10−7 1.0 × 10−6 1.2 × 10−6
95% confidence interval 9.7 × 10−7–1.5 × 10−6 3.9 × 10−7– 7.1 × 10−7 1.5 × 10−7– 2.4 × 10−7 9.6 × 10−7–1.1 × 10−6 1.0 × 10−6–1.4 × 10−6